Oliver Bisazza has been appointed as the new chief executive officer of MedTech Europe with effect from 2 January 2023, succeeding Serge Bernasconi who has announced his retirement. Bisazza is currently director general industrial policies & external affairs at MedTech Europe.
Shutterstock
Signalling new appointment
After more than 10 years as the head of MedTech Europe, Serge Bernasconi has announced his retirement and will remain MedTech Europe’s acting CEO until Bisazza takes up the role.
Rob ten Hoedt, chairman of the Board of MedTech Europe, said: “We are thankful to Serge for his engagement, leadership, successes, development and transformation of MedTech Europe over the last 10 years. He leaves behind a strong, very professional and highly respected organisation. We wish him the best for his well-deserved retirement. We are very pleased that Oliver Bisazza has accepted the position of CEO of MedTech Europe. He has a broad and quite unique experience, from both the industry and different trade associations, as well as a solid knowledge of the key dossiers we are involved with and of the EU institutions, which we believe will be very valuable for our organisation and industry.”
Oliver Bisazza is an Australian-Maltese national with 15 years of professional experience in Brussels. Approximately 10 of those years have been spent in Industrial Policies roles in trade associations representing the medical technology and other industries. Prior to joining MedTech Europe in 2017, he worked at the medical devices manufacturer Medtronic, as director of regulatory policy for the Europe, Middle East and Africa region.
Bisazza said: “I am deeply honoured to lead MedTech Europe in service of this highly-innovative healthcare industry. Medical technologies continue to offer vast and exciting opportunities to help meet the social, economic and healthcare challenges facing Europe. I am looking forward, with the support and engagement of MedTech Europe’s team, its Board, and members, to ensuring access to medical technologies to patients, healthcare professionals and healthcare systems in Europe and the rest of the world.
